Collister John P, Hendel Michael D
University of Minnesota, Department of Veterinary PathoBiology, St. Paul 55108, USA.
J Renin Angiotensin Aldosterone Syst. 2003 Sep;4(3):176-9. doi: 10.3317/jraas.2003.028.
The following studies were designed to test the hypothesis that Ang (1-7) contributes to the chronic hypotensive effects of the angiotensin II AT(1)-receptor antagonist, losartan, in normal rats.
We have previously shown a chronic, hypotensive response to the AT(1)-receptor antagonist, losartan, in normotensive rats. The mechanism of this response is not completely understood. Previous studies by others have demonstrated a role for Ang (1-7) in the beneficial antihypertensive effects of angiotensin-converting enzyme (ACE) inhibition. This is thought to be due to vasodilatory effects of increased levels of Ang (1-7) during ACE inhibition. Since it has now been shown that Ang (1-7) levels are also increased during AT(1) antagonism, we designed experiments to test the hypothesis above.
Sprague-Dawley rats were instrumented with venous catheters and radiotelemetric pressure transducers and commenced on a normal (0.4%) NaCl diet. Arterial pressure responses were measured in rats treated with losartan (10 mg/kg/day) (LOS rats, n=8) and compared with those treated with losartan and the Ang (1-7) antagonist, A779 (24 g/kg/hour) (A779/LOS rats, n=11) for 10 days.
By day 7 of treatment, mean arterial pressure had dropped by 27+1 mmHg in LOS rats, in contrast with a decrease of only 21+2 mmHg in A779/LOS rats. This attenuated response in rats treated with A779 became more prominent and continued through day 10 of losartan treatment.
These results support the hypothesis that the chronic hypotensive effects of losartan in normal rats are mediated in part through the actions of Ang (1-7).
以下研究旨在验证血管紧张素(1 - 7)[Ang (1 - 7)]在正常大鼠中对血管紧张素II 1型受体拮抗剂氯沙坦的慢性降压作用有影响这一假设。
我们之前已表明,正常血压大鼠对1型受体拮抗剂氯沙坦会产生慢性降压反应。这种反应的机制尚未完全明确。其他人之前的研究已证明Ang (1 - 7)在血管紧张素转换酶(ACE)抑制的有益降压作用中发挥作用。这被认为是由于ACE抑制期间Ang (1 - 7)水平升高产生的血管舒张作用。由于现已表明在1型受体拮抗期间Ang (1 - 7)水平也会升高,我们设计了实验来验证上述假设。
给斯普拉格 - 道利大鼠植入静脉导管和无线电遥测压力传感器,并开始给予正常(0.4%)氯化钠饮食。测量用氯沙坦(10毫克/千克/天)治疗的大鼠(氯沙坦组大鼠,n = 8)的动脉血压反应,并与用氯沙坦和Ang (1 - 7)拮抗剂A779(24微克/千克/小时)治疗的大鼠(A779/氯沙坦组大鼠,n = 11)进行比较,持续10天。
到治疗第7天,氯沙坦组大鼠的平均动脉压下降了27±1毫米汞柱,相比之下,A779/氯沙坦组大鼠仅下降了21±2毫米汞柱。在用A779治疗的大鼠中这种减弱的反应变得更加明显,并在氯沙坦治疗的第10天持续存在。
这些结果支持以下假设,即氯沙坦在正常大鼠中的慢性降压作用部分是通过Ang (1 - 7)的作用介导的。